Bill Sponsor
New York Assembly Bill 6506
Session 2023-2024
Prohibits the sale of xylazine
Active
Active
Passed Assembly on Mar 18, 2024
First Action
Apr 12, 2023
Latest Action
Mar 18, 2024
Origin Chamber
Assembly
Type
Bill
Bill Number
6506
State
New York
Session
2023-2024
Sponsorship by Party
Assembly Votes (2)
Motion Text
Assembly Vote - Vote 2
Assembly Roll Call Votes
Summary
Prohibits the sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.
Actions (17)
03/18/2024
Senate
REFERRED TO CONSUMER PROTECTION
03/18/2024
Assembly
DELIVERED TO SENATE
03/18/2024
Assembly
PASSED ASSEMBLY
01/03/2024
Assembly
ORDERED TO THIRD READING CAL.186
01/03/2024
Senate
RETURNED TO ASSEMBLY
01/03/2024
Senate
DIED IN SENATE
05/31/2023
Senate
REFERRED TO CONSUMER PROTECTION
05/31/2023
Assembly
DELIVERED TO SENATE
05/31/2023
Assembly
PASSED ASSEMBLY
05/30/2023
Assembly
ORDERED TO THIRD READING RULES CAL.380
05/30/2023
Assembly
RULES REPORT CAL.380
05/30/2023
Assembly
REPORTED
05/23/2023
Assembly
REPORTED REFERRED TO RULES
05/18/2023
Assembly
PRINT NUMBER 6506A
05/18/2023
Assembly
AMEND AND RECOMMIT TO CODES
05/16/2023
Assembly
REPORTED REFERRED TO CODES
04/12/2023
Assembly
REFERRED TO CONSUMER AFFAIRS AND PROTECTION